Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
70.82
-3.58 (-4.81%)
At close: Oct 13, 2026, 4:00 PM EDT
68.91
-1.91 (-2.70%)
After-hours: Oct 13, 2026, 7:30 PM EDT
Tarsus Pharmaceuticals Market Cap
Tarsus Pharmaceuticals has a market cap or net worth of $3.11 billion as of October 13, 2026. It is the 4,902nd most valuable company in the world and the 1,443rd biggest in the United States. Its market cap has increased by 4.96% in one year.
Market Cap
3.11B
Enterprise Value
2.75B
1-Year Change
4.96%
Global Rank
Country Rank
#1,443 United States
Category
ChartMarket Cap Chart
Since the IPO on October 16, 2020, Tarsus Pharmaceuticals's market cap has increased from $308.14M to $3.11B, an increase of 908.55%. That is a compound annual growth rate of 47.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 3.11B | -10.59% |
| Dec 31, 2025 | 3.48B | 64.21% |
| Dec 31, 2024 | 2.12B | 215.74% |
| Dec 29, 2023 | 670.37M | 71.44% |
| Dec 30, 2022 | 391.01M | -15.95% |
| Dec 31, 2021 | 465.23M | -44.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Parabilis Medicines | 3.59B |
| Legend Biotech | 3.53B |
| Xenon Pharmaceuticals | 3.50B |
| IDEAYA Biosciences | 3.49B |
| Acadia Pharmaceuticals | 3.37B |
| Viking Therapeutics | 3.32B |
| Arcutis Biotherapeutics | 3.30B |
| Celcuity | 3.24B |